# A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)

> **NCT01542866** · NA · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 160 (actual)

## Conditions studied

- Age Related Macular Degeneration (AMD)

## Interventions

- **OTHER:** Health Management Tool (HMT)

## Key facts

- **NCT ID:** NCT01542866
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-11
- **Primary completion:** 2011-11-30
- **Final completion:** 2011-11-30
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2018-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01542866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01542866, "A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01542866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*